Inovio Pharmaceuticals
INO
NASDAQ
IPO1998
about INO
Inovio Pharmaceuticals is a biopharmaceutical company focused on developing immune-oncology treatments for cancers and infectious diseases, utilizing electroporation technology to deliver DNA-based therapeutics.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $1.72 | $1.77 | $1.65 | $114.05M | 924.61K |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$0.87 | n/a | n/a | 0% | 0% | 0% |